IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation-Reference-Cited by-同舟云学术

IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation

Published:2019-12 Issue:6 Volume:144 Page:1624-1637.e10
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Allinne Jeanne,Scott George,Lim Wei Keat,Birchard Dylan,Erjefält Jonas S.,Sandén Caroline,Ben Li-Hong,Agrawal Amit,Kaur Navneet,Kim Jee Hae,Kamat Vishal,Fury Wen,Huang Tammy,Stahl Neil,Yancopoulos George D.,Murphy Andrew J.,Sleeman Matthew A.,Orengo Jamie M.

Funder

Regeneron Pharmaceuticals

Sanofi

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference85 articles.

1. Mechanisms of airway remodeling;Hirota;Chest,2013

2. The asthma-COPD overlap syndrome;Postma;N Engl J Med,2015

3. Severe exacerbations predict excess lung function decline in asthma;Bai;Eur Respir J,2007

4. Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma;Ortega;J Allergy Clin Immunol Pract,2018

5. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers;Makris;Respir Med,2007

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetic/target engagement modelling of tozorakimab in healthy volunteers and patients with chronic obstructive pulmonary disease;British Journal of Clinical Pharmacology;2024-08-25

2. IL-33 released during challenge phase regulates allergic asthma in an age-dependent way;Cellular & Molecular Immunology;2024-08-12

3. Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate‐to‐severe atopic dermatitis: Results from two terminated phase II trials;Clinical and Translational Science;2024-07-30

4. Advances in non-type 2 severe asthma: from molecular insights to novel treatment strategies;European Respiratory Journal;2024-05-02

5. The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma;European Respiratory Journal;2024-03-07